1887

Chapter 73 : Special Phenotypic Methods for Detecting Antibacterial Resistance*

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Special Phenotypic Methods for Detecting Antibacterial Resistance*, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch73-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch73-2.gif
There is no abstract provided for this chapter. We are in the process of generating a full text preview. Please bookmark and return later.
Citation: Limbago B, Swenson J. 2015. Special Phenotypic Methods for Detecting Antibacterial Resistance*, p 1286-1313. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch73
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817381.mcm11.ch73
1. Swenson JM,, Patel JB,, Jorgensen JH,. 2011. Special phenotypic methods for detecting antibacterial resistance, p 11551179. In Versalovic J,, Carroll KC,, Funke G,, Jorgensen JH,, Landry ML,, Warnock DW (ed), Manual of Clinical Microbiology, 10th ed. ASM Press, Washington, DC.
2. Arias CA,, Murray BE. 2008. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther 6:637655.
3. Standiford HD,, De Maine JB,, Kirby WM. 1970. Antibiotic synergism of enterococci. Relation to inhibitory concentrations. Arch Intern Med 126:255259.
4. Clinical and Laboratory Standards Institute. 2012. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition. CLSI Document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2012. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Eleventh Edition. CLSI Document M02-A11. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Hindler JA,, Sahm DF. 1992. Controversies and confusion regarding antimicrobial susceptibility testing of enterococci. Antimicrob Newsl 8:6574.
7. Murray BE. 1990. The life and times of the Enterococcus. Clin Microbiol Rev 3:4665.
8. NCCLS. 1999. Methods for Determining Bactericidal Activity of Antimicrobial Agents. NCCLS, Wayne, PA.
9. Knapp CC,, Moody JA,. 1992. Tests to assess bactericidal activity, p 5.16.1115.16.33. In Isenberg HD (ed), Clinical Microbiology Procedures Handbook. American Society for Microbiology, Washington, DC.
10. Moellering RC,Jr,, Korzeniowski OM,, Sande MA,, Wennersten CB. 1979. Species-specific resistance to antimicrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis 140:203208.
11. Chow JW. 2000. Aminoglycoside resistance in enterococci. Clin Infect Dis 31:586589.
12. Kao SJ,, You I,, Clewell DB,, Donabedian SM,, Zervos MJ,, Petrin J,, Shaw KJ,, Chow JW. 2000. Detection of the high-level aminoglycoside resistance gene aph(2")-Ib in Enterococcus faecium. Antimicrob Agents Chemother 44:28762879.
13. Fines M,, Perichon B,, Reynolds P,, Sahm DF,, Courvalin P. 1999. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 43:21612164.
14. Sahm DF,, Boonlayangoor S,, Iwen PC,, Baade JL,, Woods GL. 1991. Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis. J Clin Microbiol 29:19341939.
15. Sahm DF,, Boonlayangoor S,, Schulz JE. 1991. Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis. J Clin Microbiol 29:25952598.
16. Swenson JM,, Ferraro MJ,, Sahm DF,, Clark NC,, Culver DH,, Tenover FC. 1995. Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. J Clin Microbiol 33:30083018.
17. Sahm DF,, Torres C. 1988. High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis. J Clin Microbiol 26:257260.
18. Swenson JM,, Clark NC,, Sahm DF,, Ferraro MJ,, Doern G,, Hindler J,, Jorgensen JH,, Pfaller MA,, Reller LB,, Weinstein MP,, Zabransky RJ,, Tenover FC. 1995. Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol 33:30193021.
19. Clinical and Laboratory Standards Institute. 2014. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI Document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Leclercq R,, Courvalin P. 1997. Resistance to glycopeptides in enterococci. Clin Infect Dis 24:545554.
21. Leclercq R,, Dutka-Malen S,, Duval J,, Courvalin P. 1992. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother 36:20052008.
22. Neves FP,, Ribeiro RL,, Duarte RS,, Teixeira LM,, Merquior VL. 2009. Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil. Int J Antimicrob Agents 33:211215.
23. Ostrowsky BE,, Clark NC,, Thauvin-Eliopoulos C,, Venkataraman L,, Samore MH,, Tenover FC,, Eliopoulos GM,, Moellering RC,Jr,, Gold HS. 1999. A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. J Infect Dis 180:11771185.
24. Perichon B,, Reynolds P,, Courvalin P. 1997. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 41:20162018.
25. Finks J,, Wells E,, Dyke TL,, Husain N,, Plizga L,, Heddurshetti R,, Wilkins M,, Rudrik J,, Hageman J,, Patel J,, Miller C. 2009. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg Infect Dis 15:943945.
26. McKessar SJ,, Berry AM,, Bell JM,, Turnidge JD,, Paton JC. 2000. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother 44:32243228.
27. Lebreton F,, Depardieu F,, Bourdon N,, Fines-Guyon M,, Berger P,, Camiade S,, Leclercq R,, Courvalin P,, Cattoir V. 2011. D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 55:46064612.
28. Xu X,, Lin D,, Yan G,, Ye X,, Wu S,, Guo Y,, Zhu D,, Hu F,, Zhang Y,, Wang F,, Jacoby GA,, Wang M. 2010. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 54:46434647.
29. Endtz HP,, Van Den Braak N,, Van Belkum A,, Goessens WH,, Kreft D,, Stroebel AB,, Verbrugh HA. 1998. Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol 36:592594.
30. Okabe T,, Oana K,, Kawakami Y,, Yamaguchi M,, Takahashi Y,, Okimura Y,, Honda T,, Katsuyama T. 2000. Limitations of Vitek GPS-418 cards in exact detection of vancomycin-resistant enterococci with the vanB genotype. J Clin Microbiol 38:24092411.
31. Sahm DF,, Kissinger J,, Gilmore MS,, Murray PR,, Mulder R,, Solliday J,, Clarke B. 1989. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 33:15881591.
32. Sahm DF,, Olsen L. 1990. In vitro detection of enterococcal vancomycin resistance. Antimicrob Agents Chemother 34:18461848.
33. Swenson JM,, Hill BC,, Thornsberry C. 1989. Problems with the disk diffusion test for detection of vancomycin resistance in enterococci. J Clin Microbiol 27:21402142.
34. Tenover FC,, Swenson JM,, O’Hara CM,, Stocker SA. 1995. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol 33:15241527.
35. Willey BM,, Kreiswirth BN,, Simor AE,, Willaims G,, Scriver SR,, Phillips A,, Low DE. 1992. Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol 30:16211624.
36. Garcia-Garrote F,, Cercenado E,, Bouza E. 2000. Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol 38:21082111.
37. Chen YS,, Marshall SA,, Winokur PL,, Coffman SL,, Wilke WW,, Murray PR,, Spiegel CA,, Pfaller MA,, Doern GV,, Jones RN. 1998. Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci. J Clin Microbiol 36:29963001.
38. Iwen PC,, Kelly DM,, Linder J,, Hinrichs SH. 1996. Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J Clin Microbiol 34:17791783.
39. Jett B,, Free L,, Sahm DF. 1996. Factors influencing the Vitek gram-positive susceptibility system’s detection of vanB-encoded vancomycin resistance among enterococci. J Clin Microbiol 34:701706.
40. Abele-Horn M,, Hommers L,, Trabold R,, Frosch M. 2006. Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci. J Clin Microbiol 44:7176.
41. Eltringham I. 1997. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 35: 18.
42. Fahr AM,, Eigner U,, Armbrust M,, Caganic A,, Dettori G,, Chezzi C,, Bertoncini L,, Benecchi M,, Menozzi MG. 2003. Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp. J Clin Microbiol 41:11351142.
43. Nakasone I,, Kinjo T,, Yamane N,, Kisanuki K,, Shiohira CM. 2007. Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing. Diagn Microbiol Infect Dis 58:191198.
44. Stefaniuk E,, Baraniak A,, Gniadkowski M,, Hryniewicz W. 2003. Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice. Eur J Clin Microbiol Infect Dis 22:479485.
45. van Den Braak N,, Goessens W,, van Belkum A,, Verbrugh HA,, Endtz HP. 2001. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. J Clin Microbiol 39:351353.
46. Carroll KC,, Borek AP,, Burger C,, Glanz B,, Bhally H,, Henciak S,, Flayhart DC. 2006. Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci. J Clin Microbiol 44:20722077.
47. NCCLS. 1993. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M7-A3. NCCLS, Villanova, PA.
48. Swenson JM,, Clark NC,, Ferraro MJ,, Sahm DF,, Doern G,, Pfaller MA,, Reller LB,, Weinstein MP,, Zabransky RJ,, Tenover FC. 1994. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol 32:17001704.
49. Free L,, Sahm DF. 1995. Investigation of the reformulated Remel Synergy Quad plate for detection of high-level aminoglycoside and vancomycin resistance among enterococci. J Clin Microbiol 33:16431645.
50. Van Horn KG,, Gedris CA,, Rodney KM,, Mitchell JB. 1996. Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci. J Clin Microbiol 34:20422044.
51. Cartwright CP,, Stock F,, Fahle GA,, Gill VJ. 1995. Comparison of pigment production and motility tests with PCR for reliable identification of intrinsically vancomycin-resistant enterococci. J Clin Microbiol 33:19311933.
52. Freeman C,, Robinson A,, Cooper B,, Mazens-Sullivan M,, Quintiliani R,, Nightingale C. 1995. In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn Microbiol Infect Dis 21:4750.
53. Ramotar K,, Woods W,, Larocque L,, Toye B. 2000. Comparison of phenotypic methods to identify enterococci intrinsically resistant to vancomycin (VanC VRE). Diagn Microbiol Infect Dis 36:119124.
54. Frank KL,, Del Pozo JL,, Patel R. 2008. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 21:111133.
55. Mateo M,, Maestre JR,, Aguilar L,, Cafini F,, Puente P,, Sanchez P,, Alou L,, Gimenez MJ,, Prieto J. 2005. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis. J Antimicrob Chemother 56:287291.
56. Swenson JM,, Skov R,, Patel JB. 2007. The cefoxitin disk test—what a clinical microbiologist needs to know. Clin Microbiol Newsl 29:3340.
57. The European Committee on Antimicrobial Susceptibility Testing. 1 January 2015. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0 http://www.eucast.org/clinical_breakpoints/.
58. Kaase M,, Lenga S,, Friedrich S,, Szabados F,, Sakinc T,, Kleine B,, Gatermann SG. 2008. Comparison of phenotypic methods for penicillinase detection in Staphylococcus aureus. Clin Microbiol Infect 14:614616.
59. Gill VJ,, Manning CB,, Ingalls CM. 1981. Correlation of penicillin minimum inhibitory concentrations and penicillin zone edge appearance with staphylococcal beta-lactamase production. J Clin Microbiol 14:437440.
60. Chambers HF. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10:781791.
61. Chambers HF,, Hackbarth CJ,. 1992. Methicillin-resistant Staphylococcus aureus: genetics and mechanisms of resistance, p 2135. In Cafferkey MT (ed), Methicillin-Resistant Staphylococcus aureus: Clinical Management and Laboratory Aspects. Marcel Dekker, Inc, New York, NY.
62. de Lencastre H,, Sa Figueiredo AM,, Urban C,, Rahal J,, Tomasz A. 1991. Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 35:632639.
63. Hackbarth CJ,, Chambers HF. 1989. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob Agents Chemother 33:991994.
64. Tomasz A,, Drugeon HB,, de Lencastre HM,, Jabes D,, McDougall L,, Bille J. 1989. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob Agents Chemother 33:18691874.
65. Garcia-Alvarez L,, Holden MT,, Lindsay H,, Webb CR,, Brown DF,, Curran MD,, Walpole E,, Brooks K,, Pickard DJ,, Teale C,, Parkhill J,, Bentley SD,, Edwards GF,, Girvan EK,, Kearns AM,, Pichon B,, Hill RL,, Larsen AR,, Skov RL,, Peacock SJ,, Maskell DJ,, Holmes MA. 2011. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 11:595603.
66. Paterson GK,, Harrison EM,, Craven EF,, Petersen A,, Larsen AR,, Ellington MJ,, Torok ME,, Peacock SJ,, Parkhill J,, Zadoks RN,, Holmes MA. 2013. Incidence and characterisation of methicillin-resistant Staphylococcus aureus (MRSA) from nasal colonisation in participants attending a cattle veterinary conference in the UK. PLoS One 8:e68463.
67. Ganesan A,, Crawford K,, Mende K,, Murray CK,, Lloyd B,, Ellis M,, Tribble DR,, Weintrob AC. 2013. Evaluation for a novel methicillin resistance (mecC) homologue in methicillin-resistant Staphylococcus aureus isolates obtained from injured military personnel. J Clin Microbiol 51:30733075.
68. Basset P,, Prod’hom G,, Senn L,, Greub G,, Blanc DS. 2013. Very low prevalence of meticillin-resistant Staphylococcus aureus carrying the mecC gene in western Switzerland. J Hosp Infect 83:257259.
69. Paterson GK,, Morgan FJ,, Harrison EM,, Cartwright EJ,, Torok ME,, Zadoks RN,, Parkhill J,, Peacock SJ,, Holmes MA. 2014. Prevalence and characterization of human mecC methicillin-resistant Staphylococcus aureus isolates in England. J Antimicrob Chemother 69:907910.
70. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillinresistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep 48:707710.
71. Palavecino E. 2004. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med 24:403418.
72. Zetola N,, Francis JS,, Nuermberger EL,, Bishai WR. 2005. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5:275286.
73. Hartman BJ,, Tomasz A. 1986. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother 29:8592.
74. Sabath LD. 1977. Chemical and physical factors influencing methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. J Antimicrob Chemother 3(Suppl C):4751.
75. Tomasz A,, Nachman S,, Leaf H. 1991. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 35:124129.
76. Swenson JM,, Tenover FC. 2005. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J Clin Microbiol 43:38183823.
77. Swenson JM,, Lonsway D,, McAllister S,, Thompson A,, Jevitt L,, Zhu W,, Patel JB. 2007. Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn Microbiol Infect Dis 58:3339.
78. Felten A,, Grandry B,, Lagrange PH,, Casin I. 2002. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-Screen latex agglutination test. J Clin Microbiol 40:27662771.
79. Mougeot C,, Guillaumat-Tailliet J,, Libert JM. 2001. Staphylococcus aureus: new detection of intrinsic resistance using the diffusion method. Pathol Biol (Paris) 49:199204.
80. Swenson JM,, Brasso WB,, Ferraro MJ,, Hardy DJ,, Knapp CC,, Lonsway D,, McAllister S,, Reller LB,, Sader HS,, Shortridge D,, Skov R,, Weinstein MP,, Zimmer BL,, Patel JB. 2009. Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp. J Clin Microbiol 47:19021905.
81. Clinical and Laboratory Standards Institute. 2009. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. CLSI Document M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
82. Cauwelier B,, Gordts B,, Descheemaecker P,, Van Landuyt H. 2004. Evaluation of a disk diffusion method with cefoxitin (30 microg) for detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 23:389392.
83. Swenson JM,, Williams PP,, Killgore G,, O’Hara CM,, Tenover FC. 2001. Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms. J Clin Microbiol 39:37853788.
84. Tee WS,, Soh SY,, Lin R,, Loo LH. 2003. Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate. J Clin Microbiol 41:519520.
85. Pereira EM,, Schuenck RP,, Nouer SA,, Santos KR. 2011. Methicillin-resistant Staphylococcus lugdunensis carrying SCCmec type V misidentified as MRSA. Braz J Infect Dis 15:293295.
86. Fernandes CJ,, Fernandes LA,, Collignon P. 2005. Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 55:506510.
87. Perez LR,, Antunes AL,, Barth AL,, d’Azevedo PA. 2007. Variations of agar screen tests for detection of methicillin resistance in staphylococci: focus on cefoxitin. Eur J Clin Microbiol Infect Dis 26:267270.
88. Smyth RW,, Kahlmeter G. 2005. Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43:37973799.
89. Stoakes L,, Reyes R,, Daniel J,, Lennox G,, John MA,, Lannigan R,, Hussain Z. 2006. Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44:637639.
90. Swenson JM,, Spargo J,, Tenover FC,, Ferraro MJ. 2001. Optimal inoculation methods and quality control for the NCCLS oxacillin agar screen test for detection of oxacillin resistance in Staphylococcus aureus. J Clin Microbiol 39:37813784.
91. Cavassini M,, Wenger A,, Jaton K,, Blanc DS,, Bille J. 1999. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 37:15911594.
92. Resende CA,, Figueiredo AM. 1997. Discrimination of methicillin-resistant Staphylococcus aureus from borderline-resistant and susceptible isolates by different methods. J Med Microbiol 46:145149.
93. Hindler JA,, Inderlied CB. 1985. Effect of the source of Mueller-Hinton agar and resistance frequency on the detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 21:205210.
94. Hindler JF,, Bruckner DA. 2005. Abstr 105th Am Soc Microbiol Gen Meet, abstr C-325. American Society for Microbiology, Washington, DC.
95. Velasco D,, del Mar Tomas M,, Cartelle M,, Beceiro A,, Perez A,, Molina F,, Moure R,, Villanueva R,, Bou G. 2005. Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 55:379382.
96. Mimica MJ,, Berezin EN,, Carvalho RL,, Mimica IM,, Mimica LM,, Safadi MA,, Schneider E,, Caiaffa-Filho HH. 2007. Detection of methicillin resistance in Staphylococcus aureus isolated from pediatric patients: is the cefoxitin disk diffusion test accurate enough? Braz J Infect Dis 11:415417.
97. Silva-Carvalho MC,, Teixeira LA,, Ferreira FA,, Ribeiro A,, Ferreira-Carvalho BT,, Figueiredo AM. 2009. Comparison of different methods for detecting methicillin resistance in MRSA isolates belonging to international lineages commonly isolated in the American continent. Microbiol Immunol 53:117122.
98. Zeeshan M,, Jabeen K,, Khan E,, Irfan S,, Ibrahim S,, Parween Z,, Zafar A. 2007. Comparison of different phenotypic methods of detection of methicillin resistance in Staphylococcus aureus with the molecular detection of mec-A gene. J Coll Physicians Surg Pak 17:666670.
99. Chambers HF,, Archer G,, Matsuhashi M. 1989. Low-level methicillin resistance in strains of Staphylococcus aureus. Antimicrob Agents Chemother 33:424428.
100. Hirano L,, Bayer AS. 1991. Beta-lactam–beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Antimicrob Agents Chemother 35:685690.
101. Thauvin-Eliopoulos C,, Rice LB,, Eliopoulos GM,, Moellering RC,Jr. 1990. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus. Antimicrob Agents Chemother 34:728732.
102. Laurent F,, Chardon H,, Haenni M,, Bes M,, Reverdy ME,, Madec JY,, Lagier E,, Vandenesch F,, Tristan A. 2012. MRSA harboring mecA variant gene mecC, France. Emerg Infect Dis 18:14651467.
103. Monecke S,, Gavier-Widen D,, Mattsson R,, Rangstrup-Christensen L,, Lazaris A,, Coleman DC,, Shore AC,, Ehricht R. 2013. Detection of mecC-positive Staphylococcus aureus (CC130-MRSA-XI) in diseased European hedgehogs (Erinaceus europaeus) in Sweden. PLoS One 8:e66166.
104. Loncaric I,, Kubber-Heiss A,, Posautz A,, Stalder GL,, Hoffmann D,, Rosengarten R,, Walzer C. 2013. Characterization of methicillin-resistant Staphylococcus spp. carrying the mecC gene, isolated from wildlife. J Antimicrob Chemother 68:22222225.
105. Garcia-Garrote F,, Cercenado E,, Marin M,, Bal M,, Trincado P,, Corredoira J,, Ballesteros C,, Pita J,, Alonso P,, Vindel A. 2014. Methicillin-resistant Staphylococcus aureus carrying the mecC gene: emergence in Spain and report of a fatal case of bacteraemia. J Antimicrob Chemother 69:4550.
106. Harrison EM,, Paterson GK,, Holden MT,, Morgan FJ,, Larsen AR,, Petersen A,, Leroy S,, De Vliegher S,, Perreten V,, Fox LK,, Lam TJ,, Sampimon OC,, Zadoks RN,, Peacock SJ,, Parkhill J,, Holmes MA. 2013. A Staphylococcus xylosus isolate with a new mecC allotype. Antimicrob Agents Chemother 57:15241528.
107. Skov R,, Larsen AR,, Kearns A,, Holmes M,, Teale C,, Edwards G,, Hill R. 2014. Phenotypic detection of mecC-MRSA: cefoxitin is more reliable than oxacillin. J Antimicrob Chemother 69:133135.
108. Cartwright EJ,, Paterson GK,, Raven KE,, Harrison EM,, Gouliouris T,, Kearns A,, Pichon B,, Edwards G,, Skov RL,, Larsen AR,, Holmes MA,, Parkhill J,, Peacock SJ,, Torok ME. 2013. Use of Vitek 2 antimicrobial susceptibility profile to identify mecC in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 51:27322734.
109. Becker K,, Larsen AR,, Skov RL,, Paterson GK,, Holmes MA,, Sabat AJ,, Friedrich AW,, Kock R,, Peters G,, Kriegeskorte A. 2013. Evaluation of a modular multiplex-PCR methicillin-resistant Staphylococcus aureus detection assay adapted for mecC detection. J Clin Microbiol 51:19171919.
110. Cuny C,, Layer F,, Strommenger B,, Witte W. 2011. Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany. PLoS One 6:e24360.
111. Paterson GK,, Morgan FJ,, Harrison EM,, Peacock SJ,, Parkhill J,, Zadoks RN,, Holmes MA. 2014. Prevalence and properties of mecC methicillin-resistant Staphylococcus aureus (MRSA) in bovine bulk tank milk in Great Britain. J Antimicrob Chemother 69:598602.
112. Martineau F,, Picard FJ,, Lansac N,, Menard C,, Roy PH,, Ouellette M,, Bergeron MG. 2000. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 44:231238.
113. Sakoulas G,, Degirolami PC,, Gold HS. 2001. Methicillin-susceptible Staphylococcus aureus: believe it, or not. Arch Intern Med 161:12371238.
114. Archer GL,, Climo MW. 1994. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 38:22312237.
115. NCCLS. 1999. Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement. NCCLS Document M100-S9. NCCLS, Wayne, PA.
116. Gradelski E,, Valera L,, Aleksunes L,, Bonner D,, Fung-Tomc J. 2001. Correlation between genotype and phenotypic categorization of staphylococci based on methicillin susceptibility and resistance. J Clin Microbiol 39:29612963.
117. Hussain Z,, Stoakes L,, Massey V,, Diagre D,, Fitzgerald V,, El Sayed S,, Lannigan R. 2000. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J Clin Microbiol 38:752754.
118. Louie L,, Majury A,, Goodfellow J,, Louie M,, Simor AE. 2001. Evaluation of a latex agglutination test (MRSA-Screen) for detection of oxacillin resistance in coagulase-negative staphylococci. J Clin Microbiol 39:41494151.
119. Ferreira RB,, Iorio NL,, Malvar KL,, Nunes AP,, Fonseca LS,, Bastos CC,, Santos KR. 2003. Coagulase-negative staphylococci: comparison of phenotypic and genotypic oxacillin susceptibility tests and evaluation of the agar screening test by using different concentrations of oxacillin. J Clin Microbiol 41:36093614.
120. Ramotar K,, Woods W,, Toye B. 2001. Oxacillin susceptibility testing of Staphylococcus saprophyticus using disk diffusion, agar dilution, broth microdilution, and the Vitek GPS-105 card. Diagn Microbiol Infect Dis 40:203205.
121. Stepanovic S,, Hauschild T,, Dakic I,, Al-Doori Z,, Svabic-Vlahovic M,, Ranin L,, Morrison D. 2006. Evaluation of phenotypic and molecular methods for detection of oxacillin resistance in members of the Staphylococcus sciuri group. J Clin Microbiol 44:934937.
122. Tenover FC,, Jones RN,, Swenson JM,, Zimmer B,, McAllister S,, Jorgensen JH. 1999. Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study. J Clin Microbiol 37:40514058.
123. CLSI. 2012. M07-A9. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition. Clinical and Laboratory Standards Institute, Wayne, PA.
124. Perazzi B,, Fermepin MR,, Malimovka A,, Garcia SD,, Orgambide M,, Vay CA,, de Torres R,, Famiglietti AM. 2006. Accuracy of cefoxitin disk testing for characterization of oxacillin resistance mediated by penicillin-binding protein 2a in coagulase-negative staphylococci. J Clin Microbiol 44:36343639.
125. Secchi C,, Antunes AL,, Perez LR,, Cantarelli VV,, d’Azevedo PA. 2008. Identification and detection of methicillin resistance in non-epidermidis coagulase-negative staphylococci. Braz J Infect Dis 12:316320.
126. John MA,, Burden J,, Stuart JI,, Reyes RC,, Lannigan R,, Milburn S,, Diagre D,, Wilson B,, Hussain Z. 2009. Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance. J Antimicrob Chemother 63:493496.
127. Higashide M,, Kuroda M,, Ohkawa S,, Ohta T. 2006. Evaluation of a cefoxitin disk diffusion test for the detection of mecA-positive methicillin-resistant Staphylococcus saprophyticus. Int J Antimicrob Agents 27:500504.
128. Palazzo IC,, Darini AL. 2006. Evaluation of methods for detecting oxacillin resistance in coagulase-negative staphylococci including cefoxitin disc diffusion. FEMS Microbiol Lett 257:299305.
129. Pupin H,, Renaudin H,, Join-Lambert O,, Bebear C,, Megraud F,, Lehours P. 2007. Evaluation of moxalactam with the BD Phoenix system for detection of methicillin resistance in coagulase-negative staphylococci. J Clin Microbiol 45:20052008.
130. Zhu LX,, Zhang ZW,, Wang C,, Yang HW,, Zhang Q,, Cheng J. 2006. Evaluation of the CLSI cefoxitin 30-microg disk-diffusion method for detecting methicillin resistance in staphylococci. Clin Microbiol Infect 12:10391042.
131. Flayhart D,, Lema C,, Borek A,, Carroll KC. 2004. Comparison of the BBL CHROMagar Staph aureus agar medium to conventional media for detection of Staphylococcus aureus in respiratory samples. J Clin Microbiol 42:35663569.
132. Wolk DM,, Marx JL,, Dominguez L,, Driscoll D,, Schifman RB. 2009. Comparison of MRSASelect Agar, CHROMagar methicillin-resistant Staphylococcus aureus (MRSA) medium, and Xpert MRSA PCR for detection of MRSA in nares: diagnostic accuracy for surveillance samples with various bacterial densities. J Clin Microbiol 47:39333936.
133. Peterson LR,, Liesenfeld O,, Woods CW,, Allen SD,, Pombo D,, Patel PA,, Mehta MS,, Nicholson B,, Fuller D,, Onderdonk A. 2010. Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol 48:16611666.
134. Bischof LJ,, Lapsley L,, Fontecchio K,, Jacosalem D,, Young C,, Hankerd R,, Newton DW. 2009. Comparison of chromogenic media to BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR for detection of MRSA in nasal swabs. J Clin Microbiol 47:22812283.
135. Nahimana I,, Francioli P,, Blanc DS. 2006. Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 12:11681174.
136. Paule SM,, Hacek DM,, Kufner B,, Truchon K,, Thomson RB,Jr,, Kaul KL,, Robicsek A,, Peterson LR. 2007. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol 45:29932998.
137. Paule SM,, Mehta M,, Hacek DM,, Gonzalzles TM,, Robicsek A,, Peterson LR. 2009. Chromogenic media vs real-time PCR for nasal surveillance of methicillin-resistant Staphylococcus aureus: impact on detection of MRSA-positive persons. Am J Clin Pathol 131:532539.
138. Snyder JW,, Munier GK,, Johnson CL. 2010. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from intensive care unit patients. J Clin Microbiol 48:13051309.
139. Perez LR,, Antunes AL,, Bonfanti JW,, Pinto JB,, Roesch EW,, Rodrigues D,, Dias CA. 2012. Detection of methicillin-resistant Staphylococcus aureus in clinical specimens from cystic fibrosis patients by use of chromogenic selective agar. J Clin Microbiol 50:25062508.
140. van Loo IH,, van Dijk S,, Verbakel-Schelle I,, Buiting AG. 2007. Evaluation of a chromogenic agar (MRSASelect) for the detection of meticillin-resistant Staphylococcus aureus with clinical samples in The Netherlands. J Med Microbiol 56:491494.
141. Harrington AT,, Mahlen SD,, Clarridge JE,3rd. 2010. Significantly larger numbers of methicillin-resistant Staphylococcus aureus bacteria are recovered from polymicrobial respiratory and wound sites by use of chromogenic primary media than by use of conventional culture. J Clin Microbiol 48:13501353.
142. Wendt C,, Havill NL,, Chapin KC,, Boyce JM,, Dickenson R,, Eigner U,, Schutt S,, Fahr AM. 2010. Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in different specimens. J Clin Microbiol 48:22232227.
143. Riedel S,, Dam L,, Stamper PD,, Shah SA,, Carroll KC. 2010. Evaluation of Bio-Rad MRSASelect agar for detection of methicillin-resistant Staphylococcus aureus directly from blood cultures. J Clin Microbiol 48:22852288.
144. Pape J,, Wadlin J,, Nachamkin I. 2006. Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. J Clin Microbiol 44:25752576.
145. Peterson JF,, Dionisio AA,, Riebe KM,, Hall GS,, Wilson DA,, Whittier S,, Dipersio JR,, Ledeboer NA. 2010. Alternative use for spectra MRSA chromogenic agar in detection of methicillin-resistant Staphylococcus aureus from positive blood cultures. J Clin Microbiol 48:22652267.
146. Brown DF,, Walpole E. 2001. Evaluation of the Mastalex latex agglutination test for methicillin resistance in Staphylococcus aureus grown on different screening media. J Antimicrob Chemother 47:187189.
147. Mohanasoundaram KM,, Lalitha MK. 2008. Comparison of phenotypic versus genotypic methods in the detection of methicillin resistance in Staphylococcus aureus. Indian J Med Res 127:7884.
148. Sakoulas G,, Gold HS,, Venkataraman L,, DeGirolami PC,, Eliopoulos GM,, Qian Q. 2001. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol 39:39463951.
149. Yamazumi T,, Furuta I,, Diekema DJ,, Pfaller MA,, Jones RN. 2001. Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol 39:36333636.
150. Horstkotte MA,, Knobloch JK,, Rohde H,, Mack D. 2001. Rapid detection of methicillin resistance in coagulase-negative staphylococci by a penicillin-binding protein 2a-specific latex agglutination test. J Clin Microbiol 39:37003702.
151. Hussain Z,, Stoakes L,, Garrow S,, Longo S,, Fitzgerald V,, Lannigan R. 2000. Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test. J Clin Microbiol 38:20512054.
152. Marlowe EM,, Linscott AJ,, Kanatani M,, Bruckner DA. 2002. Practical therapeutic application of the oxoid PBP2' latex agglutination test for the rapid identification of methicillin-resistant Staphylococcus aureus in blood cultures. Am J Clin Pathol 118:287291.
153. Knausz M,, Ghidan A,, Grossato A,, Rozgonyi F. 2005. Rapid detection of methicillin resistance in teicoplanin-resistant coagulase-negative staphylococci by a penicillin-binding protein 2' latex agglutination method. J Microbiol Methods 60:413416.
154. Cornaglia G,, Rossolini GM. 2009. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens. Clin Microbiol Infect 15:218223.
155. Lodise TP,, Patel N,, Renaud-Mutart A,, Gorodecky E,, Fritsche TR,, Jones RN. 2008. Pharmacokinetic and pharmacodynamic profile of ceftobiprole. Diagn Microbiol Infect Dis 61:96102.
156. Zhanel GG,, Sniezek G,, Schweizer F,, Zelenitsky S,, Lagace-Wiens PR,, Rubinstein E,, Gin AS,, Hoban DJ,, Karlowsky JA. 2009. Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus. Drugs 69:809831.
157. Knapp CC,, Ludwig MD,, Washington JA,, Chambers HF. 1996. Evaluation of Vitek GPS-SA card for testing of oxacillin against borderline-susceptible staphylococci that lack mec. J Clin Microbiol 34:16031605.
158. Montanari MP,, Massidda O,, Mingoia M,, Varaldo PE. 1996. Borderline susceptibility to methicillin in Staphylococcus aureus: a new mechanism of resistance? Microb Drug Resist(Larchmont, NY) 2:257260.
159. Massanari RM,, Pfaller MA,, Wakefield DS,, Hammons GT,, McNutt LA,, Woolson RF,, Helms CM. 1988. Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infections. J Infect Dis 158:702709.
160. Pefanis A,, Thauvin-Eliopoulos C,, Eliopoulos GM,, Moellering RC,Jr. 1993. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus. Antimicrob Agents Chemother 37:507511.
161. Roghmann MC. 2000. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 160:10011004.
162. Clinical and Laboratory Standards Institute. 2006. M100-S16. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
163. Tenover FC,, Moellering RC,Jr. 2007. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 44:12081215.
164. Sievert DM,, Rudrik JT,, Patel JB,, McDonald LC,, Wilkins MJ,, Hageman JC. 2008. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46:668674.
165. Limbago BM,, Kallen AJ,, Zhu W,, Eggers P,, McDougal LK,, Albrecht VS. 2014. Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States. J Clin Microbiol 52:9981002.
166. Moravvej Z,, Estaji F,, Askari E,, Solhjou K,, Naderi Nasab M,, Saadat S. 2013. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains. Int J Antimicrob Agents 42:370371.
167. Saha B,, Singh AK,, Ghosh A,, Bal M. 2008. Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 57:7279.
168. Aligholi M,, Emaneini M,, Jabalameli F,, Shahsavan S,, Dabiri H,, Sedaght H. 2008. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract 17:432434.
169. Melo-Cristino J,, Resina C,, Manuel V,, Lito L,, Ramirez M. 2013. First case of infection with vancomycin-resistant Staphylococcus aureus in Europe. Lancet 382:205.
170. Rossi F,, Diaz L,, Wollam A,, Panesso D,, Zhou Y,, Rincon S,, Narechania A,, Xing G,, Di Gioia TS,, Doi A,, Tran TT,, Reyes J,, Munita JM,, Carvajal LP,, Hernandez-Roldan A,, Brandao D,, van der Heijden IM,, Murray BE,, Planet PJ,, Weinstock GM,, Arias CA. 2014. Transferable vancomycin resistance in a community-associated MRSA lineage. N Engl J Med 370:15241531.
171. Srinivasan A,, Dick JD,, Perl TM. 2002. Vancomycin resistance in staphylococci. Clin Microbiol Rev 15:430438.
172. Carey RB,, Patel JB,, McAllister S,, Thompson A,, Raney PM,, Tenover FC,, Ginocchio C,, Bopp C,, Dumas N,, Kohlerschmidt D. 2004. Abstr 44th Intersci Conf Antimicrob Agents Chemother, abstr D-66. American Society for Microbiology, Washington, DC.
173. Madhavan T,, Sievery D,, Rudrik J,, Torresan J,, Schulman D. 2005. Abstr 43rd IDSA Annu Meet, abstr 1073.
174. Tenover FC,, Lancaster MV,, Hill BC,, Steward CD,, Stocker SA,, Hancock GA,, O’Hara CM,, McAllister SK,, Clark NC,, Hiramatsu K. 1998. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 36:10201027.
175. Aubert G,, Passot S,, Lucht F,, Dorche G. 1990. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection. J Antimicrob Chemother 25:491493.
176. Dunne WM,Jr,, Qureshi H,, Pervez H,, Nafziger DA. 2001. Staphylococcus epidermidis with intermediate resistance to vancomycin: elusive phenotype or laboratory artifact? Clin Infect Dis 33:135137.
177. Krcmery V,Jr,, Trupl J,, Drgona L,, Lacka J,, Kukuckova E,, Oravcova E. 1996. Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin. Eur J Clin Microbiol Infect Dis 15:259261.
178. Sanyal D,, Johnson AP,, George RC,, Cookson BD,, Williams AJ. 1991. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis. Lancet 337:54.
179. Schwalbe RS,, Stapleton JT,, Gilligan PH. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 316:927931.
180. Veach LA,, Pfaller MA,, Barrett M,, Koontz FP,, Wenzel RP. 1990. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 28:20642068.
181. Nunes AP,, Teixeira LM,, Iorio NL,, Bastos CC,, de Sousa Fonseca L,, Souto-Padron T,, dos Santos KR. 2006. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening. Int J Antimicrob Agents 27:307315.
182. Biedenbach DJ,, Bell JM,, Sader HS,, Turnidge JD,, Jones RN. 2009. Activities of dalbavancin against a worldwide collection of 81,673 Gram-positive bacterial isolates. Antimicrob Agents Chemother 53:12601263.
183. Swenson JM,, Anderson KF,, Lonsway DR,, Thompson A,, McAllister SK,, Limbago BM,, Carey RB,, Tenover FC,, Patel JB. 2009. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 47:20132017.
184. Prakash V,, Lewis JS,2nd,, Jorgensen JH. 2008. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother 52:4528.
185. Hiramatsu K,, Aritaka N,, Hanaki H,, Kawasaki S,, Hosoda Y,, Hori S,, Fukuchi Y,, Kobayashi I. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:16701673.
186. Walsh TR,, Bolmstrom A,, Qwarnstrom A,, Ho P,, Wootton M,, Howe RA,, MacGowan AP,, Diekema D. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 39:24392444.
187. Wootton M,, MacGowan AP,, Walsh TR,, Howe RA. 2007. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol 45:329332.
188. Riederer K,, Shemes S,, Chase P,, Musta A,, Mar A,, Khatib R. 2011. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and agar screening methods. J Clin Microbiol 49:21472150.
189. Satola SW,, Farley MM,, Anderson KF,, Patel JB. 2011. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol 49:177183.
190. van Hal SJ,, Wehrhahn MC,, Barbagiannakos T,, Mercer J,, Chen D,, Paterson DL,, Gosbell IB. 2011. Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates. J Clin Microbiol 49:14891494.
191. Yusof A,, Engelhardt A,, Karlsson A,, Bylund L,, Vidh P,, Mills K,, Wootton M,, Walsh TR. 2008. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. J Clin Microbiol 46:30423047.
192. Richter SS,, Satola SW,, Crispell EK,, Heilmann KP,, Dohrn CL,, Riahi F,, Costello AJ,, Diekema DJ,, Doern GV. 2011. Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States. J Clin Microbiol 49:42034207.
193. Fiebelkorn KR,, Crawford SA,, McElmeel ML,, Jorgensen JH. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 41:47404744.
194. Ajantha GS,, Kulkarni RD,, Shetty J,, Shubhada C,, Jain P. 2008. Phenotypic detection of inducible clindamycin resistance among Staphylococcus aureus isolates by using the lower limit of recommended inter-disk distance. Indian J Pathol Microbiol 51:376378.
195. Steward CD,, Raney PM,, Morrell AK,, Williams PP,, McDougal LK,, Jevitt L,, McGowan JE,Jr,, Tenover FC. 2005. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol 43:17161721.
196. Zelazny AM,, Ferraro MJ,, Glennen A,, Hindler JF,, Mann LM,, Munro S,, Murray PR,, Reller LB,, Tenover FC,, Jorgensen JH. 2005. Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in staphylococci: a CLSI collaborative study. J Clin Microbiol 43:26132615.
197. Jorgensen JH,, Crawford SA,, McElmeel ML,, Fiebelkorn KR. 2004. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol 42: 18001802.
198. Swenson JM,, Brasso WB,, Ferraro MJ,, Hardy DJ,, Knapp CC,, McDougal LK,, Reller LB,, Sader HS,, Shortridge D,, Skov R,, Weinstein MP,, Zimmer BL,, Patel JB. 2007. Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells. J Clin Microbiol 45:39543957.
199. Lewis JS,2nd,, Jorgensen JH. 2005. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 40:280285.
200. Cookson BD. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 41:1118.
201. Swenson JM,, Wong B,, Simor AE,, Thomson RB,, Ferraro MJ,, Hardy DJ,, Hindler J,, Jorgensen J,, Reller LB,, Traczewski M,, McDougal LK,, Patel JB. 2010. Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus. J Clin Microbiol 48:24692475.
202. Slocombe B,, Perry C. 1991. The antimicrobial activity of mupirocin—an update on resistance. J Hosp Infect 19(Suppl B):1925.
203. Seah C,, Alexander DC,, Louie L,, Simor A,, Low DE,, Longtin J,, Melano RG. 2012. MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus. Antimicrob Agents Chemother 56:19161920.
204. Simor AE,, Stuart TL,, Louie L,, Watt C,, Ofner-Agostini M,, Gravel D,, Mulvey M,, Loeb M,, McGeer A,, Bryce E,, Matlow A. 2007. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 51:38803886.
205. Simor AE,, Phillips E,, McGeer A,, Konvalinka A,, Loeb M,, Devlin HR,, Kiss A. 2007. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 44:178185.
206. Creagh S,, Lucey B. 2007. Interpretive criteria for mupirocin susceptibility testing of Staphylococcus spp. using CLSI guidelines. Br J Biomed Sci 64:15.
207. de Oliveira NE,, Cardozo AP,, Marques Ede A,, dos Santos KR,, Giambiagi-deMarval M. 2007. Interpretive criteria to differentiate low- and high-level mupirocin resistance in Staphylococcus aureus. J Med Microbiol 56:937939.
208. Finlay JE,, Miller LA,, Poupard JA. 1997. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 41:11371139.
209. Fuchs PC,, Jones RN,, Barry AL. 1990. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 28:608609.
210. Mondino PJ,, Dos Santos KR,, de Freire Bastos Mdo C,, Giambiagi-deMarval M. 2003. Improvement of mupirocin E-test for susceptibility testing of Staphylococcus aureus. J Med Microbiol 52:385387.
211. Palepou MF,, Johnson AP,, Cookson BD,, Beattie H,, Charlett A,, Woodford N. 1998. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrob Chemother 42:577583.
212. Dixon JM,, Lipinski AE,, Graham ME. 1977. Detection and prevalence of pneumococci with increased resistance to penicillin. Can Med Assoc J 117:11591161.
213. Jacobs MR,, Koornhof HJ,, Robins-Browne RM,, Stevenson CM,, Vermaak ZA,, Freiman I,, Miller GB,, Witcomb MA,, Isaacson M,, Ward JI,, Austrian R. 1978. Emergence of multiply resistant pneumococci. N Engl J Med 299:735740.
214. Swenson JM,, Hill BC,, Thornsberry C. 1986. Screening pneumococci for penicillin resistance. J Clin Microbiol 24:749752.
215. Doern GV,, Brueggemann AB,, Pierce G. 1997. Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 16:311314.
216. Leclercq R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34:482492.
217. Lewis JS,2nd,, Lepak AJ,, Thompson GR,3rd,, Craig WA,, Andes DR,, Sabol-Dzintars KE,, Jorgensen JH. 2014. Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections. Antimicrob Agents Chemother 58:13271331.
218. Verani JR,, McGee L,, Schrag SJ. 2010. Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 59:136.
219. Uh Y,, Shin DH,, Jang IH,, Hwang GY,, Lee MK,, Yoon KJ,, Kim HY. 2004. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea. J Antimicrob Chemother 53:10951097.
220. Seppala H,, Haanpera M,, Al-Juhaish M,, Jarvinen H,, Jalava J,, Huovinen P. 2003. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother 52:636644.
221. Raney PM,, Tenover FC,, Carey RB,, McGowan JE,Jr,, Patel JB. 2006. Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci. Diagn Microbiol Infect Dis 55:213218.
222. Jorgensen JH,, McElmeel ML,, Fulcher LC,, McGee L,, Glennen A. 2011. Evaluation of disk approximation and single-well broth tests for detection of inducible clindamycin resistance in Streptococcus pneumoniae. J Clin Microbiol 49:33323333.
223. Bowling JE,, Owens AE,, McElmeel ML,, Fulcher LC,, Herrera ML,, Wickes BL,, Jorgensen JH. 2010. Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations. J Clin Microbiol 48:22752277.
224. Desjardins M,, Delgaty KL,, Ramotar K,, Seetaram C,, Toye B. 2004. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol 42:56205623.
225. Megged O,, Assous M,, Weinberg G,, Schlesinger Y. 2013. Inducible clindamycin resistance in beta-hemolytic streptococci and Streptococcus pneumoniae. Isr Med Assoc J 15:2730.
226. Jenkins SG,, Farrell DJ. 2009. Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis 15:12601264.
227. Nordmann P,, Cuzon G,, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228236.
228. Humphries RM,, Kelesidis T,, Dien Bard J,, Ward KW,, Bhattacharya D,, Lewinski MA. 2010. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol 59:13831386.
229. Kontopidou F,, Plachouras D,, Papadomichelakis E,, Koukos G,, Galani I,, Poulakou G,, Dimopoulos G,, Antoniadou A,, Armaganidis A,, Giamarellou H. 2011. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect 17:E9E11.
230. Giamarellou H,, Galani L,, Baziaka F,, Karaiskos I. 2013. Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 57:23882390.
231. Elemam A,, Rahimian J,, Mandell W. 2009. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis 49:271274.
232. Leclercq R,, Canton R,, Brown DF,, Giske CG,, Heisig P,, MacGowan AP,, Mouton JW,, Nordmann P,, Rodloff AC,, Rossolini GM,, Soussy CJ,, Steinbakk M,, Winstanley TG,, Kahlmeter G. 2013. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19:141160.
233. Bush K. 2001. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32:10851089.
234. Paterson DL,, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657686.
235. Hombach M,, Mouttet B,, Bloemberg GV. 2013. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC beta-lactamase-producing clinical Enterobacteriaceae isolates. J Antimicrob Chemother 68:20922098.
236. Robberts FJ,, Kohner PC,, Patel R. 2009. Unreliable extended-spectrum beta-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates. J Clin Microbiol 47:358361.
237. Jacoby GA,, Han P. 1996. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34:908911.
238. Jarlier V,, Nicolas MH,, Fournier G,, Philippon A. 1988. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867878.
239. Katsanis GP,, Spargo J,, Ferraro MJ,, Sutton L,, Jacoby GA. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J Clin Microbiol 32:691696.
240. Moland ES,, Sanders CC,, Thomson KS. 1998. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? J Clin Microbiol 36:25752579.
241. CLSI. 2010. M100-S20. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
242. Jacoby GA,, Medeiros AA. 1991. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 35:16971704.
243. Livermore DM,, Yuan M. 1996. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 38:409424.
244. Meyer KS,, Urban C,, Eagan JA,, Berger BJ,, Rahal JJ. 1993. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119:353358.
245. Shehabi AA,, Mahafzah A,, Baadran I,, Qadar FA,, Dajani N. 2000. High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum β-lactam drugs in intensive care units. Diagn Microbiol Infect Dis 36:5356.
246. Wiener J,, Quinn JP,, Bradford PA,, Goering RV,, Nathan C,, Bush K,, Weinstein RA. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517523.
247. Emery CL,, Weymouth LA. 1997. Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. J Clin Microbiol 35:20612067.
248. Winokur PL,, Canton R,, Casellas JM,, Legakis N. 2001. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32(Suppl 2):S94S103.
249. Patterson JE. 2000. Extended-spectrum beta-lactamases. Semin Respir Infect 15:299307.
250. Willems E,, Cartuyvels R,, Magerman K,, Raymaekers M,, Verhaegen J. 2013. Comparison of different phenotypic assays for the detection of extended-spectrum beta-lactamase production by inducible AmpC-producing Gram-negative bacilli. Eur J Clin Microbiol Infect Dis 32:549555.
251. Garrec H,, Drieux-Rouzet L,, Golmard JL,, Jarlier V,, Robert J. 2011. Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. J Clin Microbiol 49:10481057.
252. Aldridge KE,, Ashcraft D,, Cambre K,, Pierson CL,, Jenkins SG,, Rosenblatt JE. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother 45:12381243.
253. Jacobs MR,, Spangler SK,, Appelbaum PC. 1992. Beta-lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. Eur J Clin Microbiol Infect Dis 11:10811093.
254. Andes D,, Craig WA. 2005. Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. Clin Microbiol Infect 11(Suppl 6):1017.
255. Livermore DM. 1995. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557584.
256. Philippon A,, Arlet G,, Jacoby GA. 2002. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 46:111.
257. Bradford PA,, Urban C,, Mariano N,, Projan SJ,, Rahal JJ,, Bush K. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563569.
258. Stapleton PD,, Shannon KP,, French GL. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 43:12061210.
259. Centers for Disease Control and Prevention. 2002. Outbreak of multidrug-resistant Salmonella newport—United States, January-April 2002. MMWR Morb Mortal Wkly Rep 51:545548.
260. M’Zali FH,, Heritage J,, Gascoyne-Binzi DM,, Denton M,, Todd NJ,, Hawkey PM. 1997. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. J Antimicrob Chemother 40:823831.
261. Nadjar D,, Rouveau M,, Verdet C,, Donay L,, Herrmann J,, Lagrange PH,, Philippon A,, Arlet G. 2000. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett 187:3540.
262. Willems E,, Verhaegen J,, Magerman K,, Nys S,, Cartuyvels R. 2013. Towards a phenotypic screening strategy for emerging beta-lactamases in Gram-negative bacilli. Int J Antimicrob Agents 41:99109.
263. Coudron PE,, Moland ES,, Thomson KS. 2000. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 38:17911796.
264. Nasim K,, Elsayed S,, Pitout JD,, Conly J,, Church DL,, Gregson DB. 2004. New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Clin Microbiol 42:47994802.
265. Black JA,, Thomson KS,, Buynak JD,, Pitout JD. 2005. Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp. J Clin Microbiol 43:41684171.
266. Black JA,, Thomson KS,, Pitout JD. 2004. Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases. J Clin Microbiol 42:22032206.
267. Pasteran F,, Mendez T,, Guerriero L,, Rapoport M,, Corso A. 2009. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 47:16311639.
268. Tsakris A,, Kristo I,, Poulou A,, Themeli-Digalaki K,, Ikonomidis A,, Petropoulou D,, Pournaras S,, Sofianou D. 2009. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol 47:362367.
269. Ingram PR,, Inglis TJ,, Vanzetti TR,, Henderson BA,, Harnett GB,, Murray RJ. 2011. Comparison of methods for AmpC beta-lactamase detection in Enterobacteriaceae. J Med Microbiol 60:715721.
270. Lee W,, Jung B,, Hong SG,, Song W,, Jeong SH,, Lee K,, Kwak HS. 2009. Comparison of 3 phenotypic-detection methods for identifying plasmid-mediated AmpC beta-lactamase-producing Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis strains. Korean J Lab Med 29:448454.
271. Polsfuss S,, Bloemberg GV,, Giger J,, Meyer V,, Bottger EC,, Hombach M. 2011. Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol 49:27982803.
272. Gude MJ,, Seral C,, Saenz Y,, Gonzalez-Dominguez M,, Torres C,, Castillo FJ. 2012. Evaluation of four phenotypic methods to detect plasmid-mediated AmpC beta-lactamases in clinical isolates. Eur J Clin Microbiol Infect Dis 31:20372043.
273. Edquist P,, Ringman M,, Liljequist BO,, Wisell KT,, Giske CG. 2013. Phenotypic detection of plasmid-acquired AmpC in Escherichia coli—evaluation of screening criteria and performance of two commercial methods for the phenotypic confirmation of AmpC production. Eur J Clin Microbiol Infect Dis 32:12051210.
274. Yagi T,, Wachino J,, Kurokawa H,, Suzuki S,, Yamane K,, Doi Y,, Shibata N,, Kato H,, Shibayama K,, Arakawa Y. 2005. Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 43:25512558.
275. Ruppé E,, Bidet P,, Verdet C,, Arlet G,, Bingen E. 2006. First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J Clin Microbiol 44:42044207.
276. Tsui K,, Wong SS,, Lin LC,, Tsai CR,, Chen LC,, Huang CH. 2012. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type beta-lactamases. J Microbiol Immunol Infect 45:193199.
277. Hansen F,, Hammerum AM,, Skov RL,, Giske CG,, Sundsfjord A,, Samuelsen O. 2012. Evaluation of ROSCO Neo-Sensitabs for phenotypic detection and subgrouping of ESBL-, AmpC- and carbapenemase-producing Enterobacteriaceae. APMIS 120:724732.
278. Tan TY,, Ng LS,, He J,, Koh TH,, Hsu LY. 2009. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother 53:146149.
279. Peter-Getzlaff S,, Polsfuss S,, Poledica M,, Hombach M,, Giger J,, Bottger EC,, Zbinden R,, Bloemberg GV. 2011. Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis. J Clin Microbiol 49:29242932.
280. Ambretti S,, Gaibani P,, Berlingeri A,, Cordovana M,, Tamburini MV,, Bua G,, Landini MP,, Sambri V. 2013. Evaluation of phenotypic and genotypic approaches for the detection of class A and class B carbapenemases in Enterobacteriaceae. Microb Drug Resist (Larchmont, NY) 19:212215.
281. Queenan AM,, Bush K. 2007. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20:440458.
282. Canton R,, Akova M,, Carmeli Y,, Giske CG,, Glupczynski Y,, Gniadkowski M,, Livermore DM,, Miriagou V,, Naas T,, Rossolini GM,, Samuelsen O,, Seifert H,, Woodford N,, Nordmann P. 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413431.
283. Villegas MV,, Lolans K,, Correa A,, Kattan JN,, Lopez JA,, Quinn JP. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 51:15531555.
284. Walsh TR,, Toleman MA,, Poirel L,, Nordmann P. 2005. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 18:306325.
285. Nordmann P. 2014. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect 44:5156.
286. Bushnell G,, Mitrani-Gold F,, Mundy LM. 2013. Emergence of New Delhi metallo-beta-lactamase type 1-producing Enterobacteriaceae and non-Enterobacteriaceae: global case detection and bacterial surveillance. Int J Infect Dis 17:e325e333.
287. Johnson AP,, Woodford N. 2013. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 62:499513.
288. Poirel L,, Potron A,, Nordmann P. 2012. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67:15971606.
289. Anderson KF,, Lonsway DR,, Rasheed JK,, Biddle J,, Jensen B,, McDougal LK,, Carey RB,, Thompson A,, Stocker S,, Limbago B,, Patel JB. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45:27232725.
290. Bratu S,, Mooty M,, Nichani S,, Landman D,, Gullans C,, Pettinato B,, Karumudi U,, Tolaney P,, Quale J. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 49:30183020.
291. Giakkoupi P,, Tzouvelekis LS,, Daikos GL,, Miriagou V,, Petrikkos G,, Legakis NJ,, Vatopoulos AC. 2005. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. J Clin Microbiol 43:494496.
292. Yan JJ,, Ko WC,, Tsai SH,, Wu HM,, Wu JJ. 2001. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan. J Clin Microbiol 39:44334439.
293. Lee K,, Chong Y,, Shin HB,, Kim YA,, Yong D,, Yum JH. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 7:8891.
294. Girlich D,, Poirel L,, Nordmann P. 2012. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 50:477479.
295. Carvalhaes CG,, Picao RC,, Nicoletti AG,, Xavier DE,, Gales AC. 2010. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 65:249251.
296. Mochon AB,, Garner OB,, Hindler JA,, Krogstad P,, Ward KW,, Lewinski MA,, Rasheed JK,, Anderson KF,, Limbago BM,, Humphries RM. 2011. New Delhi metallo-beta-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies. J Clin Microbiol 49:16671670.
297. Nordmann P,, Poirel L,, Dortet L. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 18:15031507.
298. Vasoo S,, Cunningham SA,, Kohner PC,, Simner PJ,, Mandrekar JN,, Lolans K,, Hayden MK,, Patel R. 2013. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol 51:30973101.
299. Tijet N,, Boyd D,, Patel SN,, Mulvey MR,, Melano RG. 2013. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:45784580.